ELIZABETH THORNTON: Open Payments
NPI 1942432794 · PORTLAND, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,123 in 79 payments from 18 companies in 2025. Trend: 2023 $21 · 2024 $366 · 2025 $1,123
Food & beverage: $1,123
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $310 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 20 | $224 |
| ABBVIE INC. | 19 | $151 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $95 |
| PFIZER INC. | 5 | $77 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $31 |
| Phathom Pharmaceuticals, Inc. | 2 | $30 |
| Sequel Med Tech, LLC | 1 | $29 |
| Lundbeck LLC | 1 | $28 |
| Lilly USA, LLC | 1 | $22 |
Products named: RELISTOR, AIRSUPRA, BREZTRI, CAPLYTA, QULIPTA, UBRELVY, NURTEC ODT, FARXIGA.
Industry payments across OR — which companies pay providers there.
